Statistics about Health, Pharma & Medtech in United States
Statistics
- Percentage of Medicaid patients receiving new hypertension drugs by location 2017
- U.S. medical marijuana users that recommend cannabis 2016, by gender
- Highest percent saved when buying illegal over dispensary cannabis by U.S. city 2016
- Top cancer drugs paid by Medicare Part B by sales price per dosage 2014
- Rx drugs by type used widely by older Americans 2017
- Spending on direct-to-consumer drug advertising in the U.S. 2016-2018, by media type
- U.S. consumers' out-of-pocket costs for Xarelto by program and coverage 2020
- US human growth hormone market share by application 2014-2025
- U.S. prices of Xarelto compared to prices in select countries 2020
- U.S. prices of Revlimid compared to prices in select countries 2020
- U.S. drug prices at retail level compared to select countries by multiplier 2020
- U.S. drug prices at manufacturer level compared to other countries by multiplier 2020
- U.S. prices of Janumet XR compared to prices in select countries 2020
- DCIS type of breast cancer by age group in the U.S. 2015
- Substance abuse Rx drug treatment spending in the U.S. 2009-2020
- Comparison between the complexity of clinical trials 2001-2015
- Increase in clinical trials' complexity 2001-2015
- Drugs in development with potential to be first-in-class in 2016, by therapeutic area
- Market size for biomarkers in the United States by disease 2015-2024
- Annual drug spending differences from estimates in the U.S. 2001-2018
- Estimated clinical trial cost per drug by therapeutic class 2015-2017
- Share of units sold of Rx oral solid opioids in U.S. 2017 by drug
- Prescription oral solid opioids sold in U.S. by total morphine equivalents
- Decline in daily drug doses prescribed in states with medical cannabis laws in 2016
- U.S. medical cannabis market revenue by state 2016
- U.S. comparison of market penetration rate for marijuana and other substances
- U.S. adults that have not heard of personalized medicine 2018
- Reactions among U.S. adults to description of personalized medicine 2018
- Generic market share value change worldwide 2006 vs. 2016, by region
- Estimated clinical trial cost per patient by therapeutic class 2015-2017
- MMJ dispensary annual revenue U.S. 2017, by state
- U.S. medical marijuana patients openness about cannabis use 2016, by gender
- Potential size of new medical marijuana markets in U.S. 2017, by state
- Start up cost breakdown for medical and recreational marijuana retailers U.S. 2017
- U.S. medical cannabis market revenue forecast by state 2020
- U.S. opinions on insurance coverage of personalized tests and treatments in 2018
- Major concerns among adults regarding personalized medicine in the U.S. in 2018
- Secondary reasons U.S. medical marijuana patients use cannabis 2016
- Purchasing preferences of U.S. medical marijuana users 2016
- Medication abandonment among U.S. patients in 2017, by out-of-pocket cost
- Select prescription drug price percent changes in the US 2010-2017
- Generic market share change in unit volume worldwide 2006 vs. 2016, by region
- Projected decrease in brand drug spending due to patent loss in the U.S. 2014-2024
- Views on medical cannabis use in the U.S. among adults by gender 2019
- Number of persons with misuse of select Rx drug types in past month U.S. 2017
- Top U.S. states by fentanyl overdose death rate in 2016
- Total opioid prescriptions rate U.S. 2018, by state and type
- Opioid Rx rate in the U.S. 2018, by state and daily dosage
- Rx opioids dosage and supply rate U.S. 2006 vs 2018
- Phase 3 Alzheimer's drugs in development July 2019, by mechanism of action
- Phase 2 Alzheimer's drugs in development July 2019, by mechanism of action
- U.S. public opinion on antibiotic overuse 2019
- Rx opioids dosage and supply numbers U.S. 2006 vs 2018
- Prevalence of misuse of select Rx drug types in past month U.S. 2017
- U.S. cannabinoid-based pharmaceuticals market size 2020-2029 projection
- Number of MME dispensed per capita U.S. 2014-2018
- U.S. top 10 prescribed drugs based on market share 2019
- Generics prescriptions dispensed in the U.S. 2010-2019
- Anxiety among U.S. cancer patients loved ones regarding financial situation 2019
- Reasons for missing a dose of prescribed medication in the U.S. 2017, by age
- Reasons for missing a dose of prescribed medication in the U.S. 2017, by generation
- Number of persons misusing select Rx drug types in U.S. 2017, by gender
- U.S. projected prescription drug spending by payer share 2018-2026
- Opinions on medical cannabis use in U.S. adults 2019, by education
- Views on medical cannabis use among U.S. adults 2019, by generation
- Average MME dispensed per prescription U.S. 2014-2018
- Days of supply per opioid Rx U.S. 2014-2018
- U.S. net prices of Harvoni compared to gross prices in select countries 2020
- Percent change in high daily opioid dosage patients in select U.S. states 2010-2016
- Value of pharmaceutical gross-to-net reduction in the U.S. 2012-2019
- U.S. prices of Imbruvica compared to prices in select countries 2020
- List price and rebate price change of select top drugs US 2009-2015
- U.S. adults that trust their doctor in prescribing appropriate drugs
- Rebates/discounts by select companies as share of US pharma sales 2009-2013
- Retrospective rebates, discounts, and fees for brand medicines in US 2013-2015
- Opinions on alternative medicine use for cancer treatment in the U.S. in 2018, by age
- Monthly expenditure of U.S. medical marijuana users on cannabis products 2016, by age
- Support for medical marijuana legalization for select uses 2018, by age
- Opioid prescribing rate change for select U.S. states 2010-2016
- Number of MME dispensed U.S. 2014-2018
- Mean daily opioid dosage percent change for select U.S. states 2010-2016
- Active immuno-oncological agents in development U.S. 2019, by type
- Global inhalation and nasal spray generics market 2018 and 2027
- Percentage of U.S. population with at least one opioid prescription 2014-2018
- Number of patients with at least one opioid prescription U.S. 2014-2018, by gender
- Rate of patients with at least one opioid prescription U.S. 2018, by age
- Rate of patients with at least one opioid prescription U.S. 2014-2018, by gender
- Number of patients with at least one opioid prescription U.S. 2018, by age
- Rate of opioid Rx prescriptions U.S. 2014-2018, by days of supply
- Annual rate of opioid Rx prescriptions U.S. 2014-2018
- Colorado newly applied medical marijuana patients aggregated monthly from 2015-2016
- Average daily MME dispensed per Rx U.S. 2014-2018
- Change in Medicaid PMPM spending in drug categories 2021-2022
- Cost of Medicare PDP premiums in 2023, by US state
- Asthma/COPD drug PMPM spending U.S. 2019-2024
- Eszopiclone average cost per prescription fill in the U.S. 2013-2020
- Patients prescribed temazepam in the U.S. 2013-2021
- Temazepam prescriptions in the US 2013-2021
- Temazepam average cost per prescription fill in the U.S. 2013-2021
- Share of Temazepam prescriptions in the U.S. 2021, by days supplied